加速经上皮角膜交联术治疗儿童进展性圆锥角膜的三年随访
结果显示矫正远视力(CDVA)从0.32±0.28改善至0.26±0.25(logMAR,p=0.025),最大角膜曲率、中央角膜厚度及角膜厚度测量值保持稳定(p>0.05),但术后36个月后表面中央及最高隆起较12个月时增加(p<0.05)。结论认为ATE-CXL对儿童进展性圆锥角膜安全有效,可稳定角膜曲率和厚度。
要点
- 儿童进展性圆锥角膜接受ATE-CXL后36个月CDVA显著改善。
- 最大角膜曲率和中央角膜厚度在36个月内保持稳定。
- 术后36个月角膜后表面隆起较12个月时增加,需关注。
核心结论
- ATE-CXL是儿童进展性圆锥角膜安全有效的治疗,36个月随访中角膜曲率和厚度保持稳定。
主要发现
- 术后36个月CDVA从0.32±0.28改善至0.26±0.25(logMAR,p=0.025)。
- 最大角膜曲率术前为58.73±9.70 D,术后1、6、12、36个月分别为59.20±10.24、58.28±9.33、57.88±9.99、58.98±10.79 D(p>0.05)。
- 角膜中央厚度术后为492.42±33.83 µm,36个月随访中保持稳定(p>0.05)。
- 角膜后表面中央隆起和最高隆起在术后12个月稳定(p>0.05),但术后36个月增加(p<0.05)。
- 角膜厚度测量值和上皮厚度在整个随访期间保持稳定(p>0.05)。
临床怎么用
- 对于儿童进展性圆锥角膜,ATE-CXL可作为一种稳定角膜曲率和厚度的治疗选择,但需长期监测后表面隆起变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the long-term safety and efficacy of accelerated transepithelial cornealcross-linking (ATE-CXL) in children with progressive keratoconus. METHODS: Fifty-three eyes of 41 paediatric patients (34 boys, 7 girls; mean age 14.81±1.96 years) undergoing ATE-CXL were enrolled in the study. Corrected distance visual acuity (CDVA) and manifest refraction were assessed preoperatively and 36 months postoperatively. Corneal keratometry, corneal thickness and posterior elevation were measured using Pentacam preoperatively and 1, 6, 12 and 36 months postoperatively. Pachymetry and epithelial thicknesses were measured using optical coherence tomography preoperatively and 6, 12, and 36 months postoperatively. RESULTS: Thirty-six months postoperatively, CDVA improved from 0.32±0.28 to 0.26±0.25 in logarithm of the minimum angle resolution (p=0.025). Maximum keratometry was 58.73±9.70 D preoperatively and 59.20±10.24, 58.28±9.33, 57.88±9.99 and 58.98±10.79 D at 1, 6, 12 and 36 months postoperatively throughout the 36-month follow-up period (p>0.05). Similarly, corneal central thickness, which was 492.42±33.83 µm postoperatively, also remained stable during the 36-month follow-up (p>0.05). Both posterior central elevation and posterior highest elevation were stable at 12 months after ATE-CXL (p>0.05), but increased at 36 months postprocedure (p<0.05). Corneal pachymetry and epithelial thicknesses remained stable throughout the follow-up period (p>0.05). CONCLUSIONS: ATE-CXL is a safe and effective treatment in paediatric progressive keratoconus patients, leading to stable keratometry and corneal thickness throughout the 36-month follow-up.
引用
- Tian M, Jian W, Zhang X, et al. Three-year follow-up of accelerated transepithelial corneal cross-linking for progressive paediatric keratoconus. Br J Ophthalmol. 2020. PMID: 32051139. doi:10.1136/bjophthalmol-2019-315260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。